Based on the phenomenon that EGFR-TKIs induce autophagy (83, 87), and autophagy may lead to chemotherapy resistance (88), researchers speculate that autophagy may be a protective mechanism for cancer cells and contribute to the emergence of drug resistance in NSCLC. This evidence concerns the gene EGFR and cancer.